1Olver JS,O'keefe G,Jone GR,et al.Dopamine D1 receptor binding in the striatum of patients with obsessive-compulsive disorder[J].J Affect Dis,2009,114(1/3):321-326.
2Koo MS,Kim EJ,Roh D,et al.Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder[J].Expert Rev Neurother,2010,10(2):275-290.
3Rolls ET.Glutamate,obsessive-compulsive disorder,schizophrenia,and the stability of cortical attractor neuronal networks[J].Pharmacol Biochem Behav,2012,100(4):736-751.
4Ak M,Bulut SD,Bozkurt A,et al.Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder:a 10-week open-label study[J].Adv Ther,2011,28(4):341-348.
5Uguz F.Successful treatment of comorbid obsessive-compulsive disorder with aripiprazole in three patients with bipolar disorder[J].Gen Hosp Psychiatry,2010,32(5):556-558.
6Wu K,Hanna GL,Rosenberg DR,et al.The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder[J].Pharmacol Biochem Behav,2012,100(4):726-735.
7Bernhardt EB,Walsh KH,Posey DJ,et al.Memantine for comorbid obsessive-compulsive disorder and asperger disorder suggests a link in glutamatergic dysregulation[J].J Clin Psychopharmacol,2011,31(5):673-674.
8Greve KW,Adams D.Treatment of features of obsessive-compulsive personality disorder using carbamazepine[J].Psychiatry Clin Neurosci,2002,56(2):207-208.
9Poyurovsky M,Glick I,Koran LM.Lamotrigine augmentation in schizophrenia and schizoaffective patients with obsessive-compulsive symptoms[J].J Psychopharmacol,2010,24(6):861-866.
10Hollander E,Kaplan A,Stahl SM.A double-blind,placebo-controlled trial of clonazepam in obsessive-compulsive disorder[J].World Biol Psychiatry,2003,228(1):30-40.
